Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2343 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials.

Reijula E, Pietilä AM, Halkoaho A, Selander T, Martikainen K, Kälviäinen R, Keränen T.

Trials. 2017 Sep 29;18(1):444. doi: 10.1186/s13063-017-2174-2.

0

0

0

PUBMED

Chronic pain and pain processing in Parkinson's disease.

Blanchet PJ, Brefel-Courbon C.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 12. pii: S0278-5846(17)30599-7. doi: 10.1016/j.pnpbp.2017.10.010. [Epub ahead of print] Review.

0

0

0

PUBMED

Parkinson's Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32.

Gonzalez-Cano L, Menzl I, Tisserand J, Nicklas S, Schwamborn JC.

Mol Neurobiol. 2017 May 15. doi: 10.1007/s12035-017-0570-y. [Epub ahead of print]

0

0

0

PUBMED

Predictors of onset of psychosis in patients with Parkinson's disease: Who gets it early?

Lenka A, George L, Arumugham SS, Hegde S, Reddy V, Kamble N, Yadav R, Pal PK.

Parkinsonism Relat Disord. 2017 Sep 14. pii: S1353-8020(17)30344-9. doi: 10.1016/j.parkreldis.2017.09.015. [Epub ahead of print]

0

0

0

PUBMED

Breathing new life into an old target: pulmonary disease drugs for Parkinson's disease therapy.

Abdelmotilib H, West AB.

Genome Med. 2017 Oct 19;9(1):88. doi: 10.1186/s13073-017-0483-4.

0

0

0

PUBMED

Nonsinusoidal Beta Oscillations Reflect Cortical Pathophysiology in Parkinson's Disease.

Cole SR, van der Meij R, Peterson EJ, de Hemptinne C, Starr PA, Voytek B.

J Neurosci. 2017 May 3;37(18):4830-4840. doi: 10.1523/JNEUROSCI.2208-16.2017. Epub 2017 Apr 17.

0

0

0

PUBMED

Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts.

Yang F, Wolk A, Håkansson N, Pedersen NL, Wirdefeldt K.

Mov Disord. 2017 Sep 7. doi: 10.1002/mds.27120. [Epub ahead of print]

0

0

0

PUBMED

Genetic risk factors in Finnish patients with Parkinson's disease.

Ylönen S, Siitonen A, Nalls MA, Ylikotila P, Autere J, Eerola-Rautio J, Gibbs R, Hiltunen M, Tienari PJ, Soininen H, Singleton AB, Majamaa K.

Parkinsonism Relat Disord. 2017 Sep 29. pii: S1353-8020(17)30353-X. doi: 10.1016/j.parkreldis.2017.09.021. [Epub ahead of print]

0

0

0

PUBMED

Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson's Disease.

Lin WC, Chen PC, Huang CC, Tsai NW, Chen HL, Wang HC, Chou KH, Chen MH, Chen YW, Lu CH.

Front Neurol. 2017 Jun 8;8:246. doi: 10.3389/fneur.2017.00246. eCollection 2017.

0

0

0

PUBMED

Drugs for Parkinson's disease.

[No authors listed]

Med Lett Drugs Ther. 2017 Nov 20;59(1534):187-194. No abstract available.

0

0

0

PUBMED

Minimally invasive motor cortex stimulation for Parkinson's disease.

Lavano A, Guzzi G, DE Rose M, Romano M, Della Torre A, Vescio G, Deodato F, Lavano F, Volpentesta G.

J Neurosurg Sci. 2017 Feb;61(1):77-87.

0

0

0

PUBMED

Aggregation of α-Synuclein in the Gonadal Tissue of 2 Patients With Parkinson Disease.

Garrido A, Aldecoa I, Gelpi E, Tolosa E.

JAMA Neurol. 2017 Mar 13. doi: 10.1001/jamaneurol.2016.6155. [Epub ahead of print] No abstract available.

0

0

0

PUBMED

Forward flexion of trunk in Parkinson's disease patients is affected by subjective vertical position.

Mikami K, Shiraishi M, Kawasaki T, Kamo T.

PLoS One. 2017 Jul 10;12(7):e0181210. doi: 10.1371/journal.pone.0181210. eCollection 2017.

0

0

0

PUBMED

Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.

Saeed U, Compagnone J, Aviv RI, Strafella AP, Black SE, Lang AE, Masellis M.

Transl Neurodegener. 2017 Mar 28;6:8. doi: 10.1186/s40035-017-0076-6. eCollection 2017. Review.

0

0

0

PUBMED

(11) C-PE2I and (18) F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.

Li W, Lao-Kaim NP, Roussakis AA, Martín-Bastida A, Valle-Guzman N, Paul G, Loane C, Widner H, Politis M, Foltynie T, Barker RA, Piccini P.

Mov Disord. 2017 Oct 30. doi: 10.1002/mds.27183. [Epub ahead of print]

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy